- NEWS AND VIEWS
In one inbred strain of laboratory mice, late-life treatment with a GLP-1 drug extends lifespan. This effect might be more than just a consequence of calorie restriction.
By
-
Maria Emilia Fernandez
-
Maria Emilia Fernandez is in the Experimental Gerontology Section and Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
-
-
Rafael de Cabo
-
Rafael de Cabo are in the Experimental Gerontology Section and Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
-
Medications that mimic the hormone GLP-1 (glucagon-like peptide-1) have been transformative in the treatment of conditions such as obesity and type 2 diabetes. Writing in Nature, Feng et al.1 report that treating female mice with the weight-loss drug semaglutide — a GLP-1 receptor activator, or agonist — late in life improves their physiological function, slows the progression of several hallmarks of ageing and extends their lifespan.
doi: https://doi.org/10.1038/d41586-026-02468-7
References
Feng, Y. et al. Nature https://doi.org/10.1038/s41586-026-10940-7 (2026).
Article Google Scholar
Schmauck-Medina, T. et al. Nature Aging 6, 485–505 (2026).
Article PubMed Google Scholar
Rosen, C. J. & Ingelfinger J. R. N. Engl. J. Med. 394, 1313–1324 (2026).
Article PubMed Google Scholar
Nature Biotechnol. 43, 1741–1742 (2025).
Article PubMed Google Scholar
Kennedy, B. K. et al. Cell 159, 709–713 (2014).
Article PubMed Google Scholar
Athauda, D., Greig, N. H., Meissner, W. G., Foltynie, T. & Gandhi, S. J. Clin. Invest. 136, e194745 (2026).
Article PubMed Google Scholar
Di Francesco, A., Di Germanio, C., Bernier, M. & De Cabo, R. Science 362, 770–775 (2018).
Article PubMed Google Scholar
Douglass, A. M. et al. Nature 620, 154–162 (2023).
Article PubMed Google Scholar
Ahima, R. S. et al. Nature 382, 250–252 (1996).
Article PubMed Google Scholar
Di Francesco, A. et al. Nature 634, 684–692 (2024).
Article PubMed Google Scholar
Corley, M. J. et al. npj Aging 12, 88 (2026).
Article PubMed Google Scholar
Download references
Competing Interests
The authors declare no competing interests.
Related Articles
-
Read the paper: Late-life semaglutide treatment slows ageing and extends lifespan in female mice
-
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
-
A bile acid could explain how calorie restriction slows ageing
-
See all News & Views
Subjects
Latest on:
- Ageing
- Nutrition
- Therapeutics
-
Can GLP-1 drugs slow ageing? Mouse study shows promise
News
-
Late-life semaglutide treatment slows ageing and extends lifespan in female mice
Article
-
This pulsating muscle graft mimics benefits of exercise
News
-
The nutritional value of invertebrate aquatic foods
Article
-
How does Make America Healthy Again hold up against scientific scrutiny?
Spotlight
-
How do researchers choose what to work on?
News & Views
-
Patient’s own mitochondria injected into eyes in attempt to restore vision
News
-
In vivo feasibility study of humanoid robots in surgery
Article
-
When drug discovery fails: scientists share their frustrations with the process
Spotlight